See the pitch deck a psychedelics startup just used to raise $18.6 million to develop new treatments derived from the Sonoran Desert toad

A narrative synthesis of research with 5-MeO-DMT — Journal of Psychopharmacology

Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 in healthy participants — Journal of Psychopharmacology

Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks (SUNHA) — Headache